We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Antibacterial Soap Containing Triclosan Could Be Unsafe

By HospiMedica International staff writers
Posted on 20 Apr 2010
The U.S. More...
Food and Drug Administration (FDA, Silver Spring, MD, USA) has acknowledged that there could be safety concerns regarding triclosan, an ingredient found widely in consumer products, such as antibacterial soaps, toothpaste and cosmetics, clothing and toys.

In an update on the FDA website, the agency stated that triclosan is not currently known to be harmful to human beings; the FDA acknowledged that the agency is reviewing all of the available evidence on the safety of triclosan in consumer products, and that the findings of this review would be released to the public in the spring of 2011. The FDA statement also pointed out that the agency has no evidence that triclosan is any better than soap and water for cleaning purposes, but that it lacks sufficient safety evidence to recommend changing consumer use of products that contain triclosan.

"Triclosan is not currently known to be hazardous to humans. But several scientific studies have come out since the last time FDA reviewed this ingredient that merit further review,” clarified the statement. "Animal studies have shown that triclosan alters hormone regulation. However, data showing effects in animals don't always predict effects in humans. Other studies in bacteria have raised the possibility that triclosan contributes to making bacteria resistant to antibiotics.”

"It's about time FDA has finally stated its concerns about antibacterial chemicals like triclosan,” said Sarah Janssen, M.D., a staff scientist at the Natural Resources Defense Council (NRDC; New York, NY, USA), a public health advocacy group. "The public deserves to know that these so-called antibacterial products are no more effective in preventing infections than regular soap and water and may, in fact, be dangerous to their health in the long run.”

Triclosan, a polychloro phenoxy phenol, is an antibacterial and antifungal agent. It is an ingredient in many detergents, dishwashing liquids, soaps, deodorants, cosmetics, lotions, antimicrobial creams, various toothpastes, and an additive in various plastics and textiles. However, beyond its use in toothpaste to prevent gingivitis, there is no evidence that triclosan provides an extra benefit to health in other consumer products; in fact, the United States Environmental Protection Agency (EPA) has actually registered triclosan as a pesticide.

Related Links:

U.S. Food and Drug Administration
NRDC



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.